Why and How to Normalize RNA-Seq Data
In this article, we give an overview of why RNA-seq normalization is essential, and we break down different RNA-seq normalization methods to help you master your next RNA-seq analysis.
Scientific Solution Advisor, Boston (US)
The BigOmics’ Scientific Solution Advisors (SSA) are the primary solution leads with BigOmics’ customers and prospects. This is a pre-sales role, and as such the SSA works closely with BigOmics sales team and developers to ensure the best solutions are presented.
Account Executive, Boston (US)
Achieving sales, account growth, and client success objectives within a geographical territory of mid-market Biotech accounts. This includes identifying and qualifying opportunities and efficiently leveraging resources in order to bring opportunities to successful conclusions.
Sales Development Representative, Boston (US)
We are looking for a passionate and motivated Sales Development Representative with a love for selling and a tenacious and methodical approach to prospecting.
The Ultimate Guide to Public RNA-Seq and single-cell RNA-Seq Databases: a Comparative Review
The wealth of publicly available RNA-sequencing (RNA-seq) and single-cell RNA-seq (scRNA-seq) data has empowered biologists to contextualize their own data and findings, generate informed data-driven hypotheses, and discover trends across …
How to prepare your RNA-Seq and proteomics data for Omics Playground
Omics Playground is a cloud-based platform designed to provide advanced tools for the analysis of RNA-Seq and proteomics data sets. To use the platform, the RNA-seq and proteomics input data …
From sample to data to discovery: an example of platforms, reagents and software to get the most out of your experiments
Omics data is becoming ubiquitous both in biological and, increasingly, medical research. Rapid developments in reagents, sequencing technologies and analysis are constantly pushing down costs while increasing the amount of …
BigOmics closes Pre-Series A with additional investment from Eppendorf
Lugano, March 17, 2022 – BigOmics Analytics, a Swiss biodata analytics startup, announces raising additional funding from Eppendorf, a leading life science company that develops and sells instruments, consumables and …
BigOmics to assist Remix Therapeutics with omics data analysis in their mission to reprogram RNA processing
Remix Therapeutics is a Boston-based biotechnology company developing novel small molecule therapies for reprogramming RNA processing and treating disease in entirely new ways. As protein targeting therapies reach the limits …
BigOmics Raises $1.85M to Revolutionize Omics Data Analytics
Bellinzona, Switzerland, December 10, 2021 – BigOmics Analytics SA (“BigOmics”), a Swiss biodata analytics startup, announced today that it raised a total of $1.85 million in financing. This funding will …